Consort Medical plc has entered an agreement to acquire Aesica Pharmaceuticals Ltd. for £230 million. The transaction, subject to conditional shareholder approval and clearance by the German authorities, is expected to close in November.   Consort Medical is focused on developing and manufacturing disposable medical devices for drug delivery including inhaled, nasal and injectables products through its core operating division Bespak. Aesica provides contract development and manufacturing service...